MetaADEDB 2.0 @ LMMD
Methazolamide
(FLOSMHQXBMRNHR-UHFFFAOYSA-N)
Structure
SMILES
CC(=O)N=c1sc(nn1C)S(=O)(=O)N
Type(s)
Approved
ATC code(s)
S01EC05
Molecular Formula:
C5H8N4O3S2
Molecular Weight:
236.272
Log P:
0.3573
Hydrogen Bond Acceptor:
8
Hydrogen Bond Donor:
1
TPSA:
144.03
CAS Number(s):
554-57-4; 1164547-86-7
Synonym(s)
1.
Methazolamide
2.
N-Methylacetazolamide
3.
N Methylacetazolamide
External Link(s)
MeSHD008704
PubChem Compound4100
BindingDB10881
50013792
315269
50094422
ChEBI6822
94513
CHEMBLCHEMBL19
CHEMBL288100
CHEMBL1335656
DrugBankDB00703
DrugCentral1741
IUPHAR/BPS Guide to PHARMACOLOGY6828
KEGGcpd:C07764
dr:D00655
Therapeutic Target DatabaseD0C2II
ZINC12503151
100019188
253917094
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1AcidosisFAERS: 12016806CTD
US FAERS
2Angle Closure GlaucomaFAERS: 1US FAERS
3ArthralgiaFAERS: 1US FAERS
4BlindnessFAERS: 1US FAERS
5Cerebrovascular accidentFAERS: 1US FAERS
6Chest PainFAERS: 1US FAERS
7ChokingFAERS: 1US FAERS
8Choroidal DetachmentFAERS: 1US FAERS
9DeliriumFAERS: 19085335CTD
US FAERS
10Diffuse alopeciaFAERS: 1US FAERS
11Drug administration errorFAERS: 1US FAERS
12DysgeusiaFAERS: 1SIDER
US FAERS
13HeadacheFAERS: 1SIDER
US FAERS
14MyopiaFAERS: 1SIDER
US FAERS
15PolyuriaFAERS: 1SIDER
US FAERS
16Stevens-Johnson SyndromeFAERS: 1SIDER
US FAERS
17Abdominal discomfortCanada Vigilance: 1Canada Vigilance
18Agranulocytosis448845
7393540		CTD
SIDER
19Altitude Sickness6349608CTD
20Anaphylactic shockSIDER
21Anorexia1921495CTD
SIDER
22AstheniaCanada Vigilance: 1Canada Vigilance
SIDER
23Bone marrow depressionSIDER
24Cardiomegaly17124262CTD
25Chemical and Drug Induced Liver Injury7196210CTD
26Confusion9085335CTD
27CrystalluriaSIDER
28DermatitisSIDER
29DiscomfortSIDER
30Disorders of Excessive Somnolence1921495CTD
31DizzinessCanada Vigilance: 1Canada Vigilance
32DrowsinessSIDER
33DyspepsiaSIDER
34Electrolyte imbalanceSIDER
35Erythema MultiformeSIDER
36FatigueSIDER
37Fecal Incontinence9085335CTD
38Feeling abnormalSIDER
39Glaucoma4706085CTD
40GlycosuriaSIDER
41Hepatic Encephalopathy7196210CTD
42Hepatic InsufficiencySIDER
43Hepatic necrosisSIDER
44Hepatitis7196210CTD
45Hypesthesia1921495CTD
46Lethargy9085335CTD
47LeukopeniaSIDER
48MalaiseSIDER
49Metabolic acidosisSIDER
50Myopia transientSIDER
51Nausea1921495CTD
SIDER
52Nephrolithiasis2016806CTD
SIDER
53Neutropenia7393540CTD
54PancytopeniaSIDER
55Paresthesia1921495
6349608		CTD
56Psychoses, Substance-Induced9085335CTD
57Signs and Symptoms, Digestive1921495CTD
58SomnolenceSIDER
59Thrombocytopenic purpuraSIDER
60TinnitusSIDER
61Toxic Epidermal NecrolysisSIDER
62Tremor1921495CTD
63Ureteral Calculi1275042CTD
64Urinary Calculi4706085CTD
65Urinary Incontinence9085335CTD
66Urine output increasedSIDER
67UrticariaSIDER
68VertigoSIDER
69VomitingSIDER
70jaundice7196210CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.